Author(s): Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A,
Abstract Share this page
Abstract A cross-sectional study, performed at a routine human immunodeficiency virus (HIV)/AIDS clinic in Cameroon that uses the World Health Organization public health approach, showed low rates of virological failure and drug resistance at 12 and 24 months after initiation of antiretroviral therapy. Importantly, the cross-sectional study also showed that the World Health Organization recommendation for second-line treatment would be effective in almost all patients with HIV drug resistance mutations.
This article was published in Clin Infect Dis
and referenced in Journal of Antivirals & Antiretrovirals